Results 61 to 70 of about 36,146 (282)

Consensus on age‐related macular degeneration course curricula for general ophthalmologists and non‐ophthalmologist clinical staff: A Delphi study

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To define the curriculum content for two interactive learning courses on age‐related macular degeneration (AMD): (1) an advanced course tailored for general ophthalmologists and (2) a basic course for non‐ophthalmologist healthcare staff.
Filip Sommer‐Lind   +46 more
wiley   +1 more source

Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future [PDF]

open access: yes, 2019
Ocular diseases cause visual impairment and blindness, imposing a devastating impact on quality of life and a substantial societal economic burden. Many such diseases lack universally effective pharmacotherapies.
Corson, Timothy W., Park, Bomina
core   +1 more source

Power and clinical utility of mesopic microperimetry analysis strategies in age‐related macular degeneration

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose This study evaluates whether mesopic microperimetry (MMP) provides a more robust measure of retinal function compared to visual acuity (VA) in age‐related macular degeneration (AMD) clinical trials, with a focus on optimal analysis strategies. Method Fellow‐eyes of unilateral neovascular AMD were prospectively studied.
Francesco Cinque   +9 more
wiley   +1 more source

Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration

open access: yesCase Reports in Ophthalmology, 2022
This case report describes full-thickness macular hole formation after intravitreal aflibercept injections for the treatment of macular neovascularization in neovascular age-related macular degeneration (AMD).
Yasmin Ali Said   +2 more
doaj   +1 more source

Systemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration [PDF]

open access: yes, 2017
Biomarkers can help unravel mechanisms of disease and identify new targets for therapy. They can also be useful in clinical practice for monitoring disease progression, evaluation of treatment efficacy, and risk assessment in multifactorial diseases ...
Dammeier, S. (Sascha)   +11 more
core   +1 more source

Neovascular age‐related macular degeneration without drusen

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To describe the clinical characteristics and 1‐year follow‐up of patients with neovascular AMD (nAMD) without drusen in either eye. Methods This is a multicentre retrospective cohort study in three tertiary referral centres in The Netherlands. We included patients of 55 years or older with nAMD in one or both eyes, without the presence
Marc J. Sirks   +9 more
wiley   +1 more source

Comparison of the efficacy and safety of SCD411 and reference aflibercept in patients with neovascular age-related macular degeneration

open access: yesScientific Reports
To compare the efficacy and safety of the proposed aflibercept biosimilar SCD411 and reference aflibercept in patients with neovascular age-related macular degeneration, this randomized, double-masked, parallel-group, multicenter study was conducted in ...
Se Woong Kang   +8 more
doaj   +1 more source

EPH18 Neovascular Age-Related Macular Degeneration: Prevalence and Treatment With Anti-VEGF From the Perspective of the Italian National Health System [PDF]

open access: bronze, 2022
G Ronconi   +10 more
openalex   +1 more source

Characterization of retinal pigment epithelium layer in healthy and diseased retinas with high‐resolution adaptive optics transscleral flood illumination imaging

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose The retinal pigment epithelium (RPE) is critical in the pathophysiology of retinal diseases, such as age‐related macular degeneration. Adaptive optics transscleral flood illumination (AO‐TFI) offers rapid, detailed morphometric characterization of the RPE layer.
Leila Sara Eppenberger   +8 more
wiley   +1 more source

Spotlight on Faricimab in the Treatment of Wet Age-Related Macular Degeneration: Design, Development and Place in Therapy

open access: yesDrug Design, Development and Therapy, 2022
Archana A Nair, Avni P Finn, Paul Sternberg Jr Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN, USACorrespondence: Paul Sternberg Jr, Chair and G. W.
Nair AA, Finn AP, Sternberg P Jr
doaj  

Home - About - Disclaimer - Privacy